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ABSTRACT  
Objectives: The values of acceleration capacity and deceleration capacity are known to capture 
fetal neurological development. The fetal growth restriction was found to be featured by 
decreased variables of phase rectified signal averaging. We have speculated that acceleration 
capacity and deceleration capacity could be of use in the detection of antenatal fetal distress 
during fetal growth restriction. The study was focused on the detection of the accuracy of 
acceleration capacity and deceleration capacity in diagnosing fetal distress. 
Material and methods: In total, 124 pregnant women at 26–36 weeks of gestation were 
included in the study. The patients with appropriate to gestational age fetuses (n = 32) were 
enrolled in Group I.  The patients with fetal growth restriction and an absence of fetal distress (n 
= 48) were observed in Group II. Lastly, the patients with fetal growth restriction and fetal 
distress (n = 44) were included in Group III. Fetal cardiosignals were obtained via non-invasive 
fetal electrocardiography. The maximally decreased acceleration capacity and deceleration 
capacity values were found in Group III.  
Results: A correlation was found between umbilical artery resistance index and acceleration 
capacity and deceleration capacity variables in all study groups.  We have found that the 
application of phase rectified signal averaging in the antenatal period showed high sensitivity 
and specificity in fetal distress detection.  
Conclusions: Fetal acceleration capacity and deceleration capacity is a prospective option for 
the detection of fetal compromise during fetal growth restriction. 
Key words: fetal growth restriction; fetal non-invasive electrocardiography; acceleration 
capacity and deceleration capacity; fetal distress 
 
INTRODUCTION 
Fetal neurological development and maturation change cardiovascular response to its 
intrauterine activity. The investigation of heart rate variability (HRV) provides a piece of 
objective information about fetal health. The variations of the cardiocycles duration are a 
“window” into fetal life. Fetal non-invasive electrocardiography is a challenging technique for 
the detection of fetal cardiosignals. The variables of fetal HRV are known to reflect its status [1].   
The conventional biophysical marker of fetal well-being is the reactivity of fetal heart 
rate in the non-stress test (NST) [2]. The absence of the accelerations on the fetal heart rate 
tracing could be associated with fetal compromise or fetal “sleep”. Thus, NST is not specific in 
diagnosing fetal distress [3].  
The values of phase rectified signal averaging are known to capture fetal neurological 
development. The fetal growth restriction (FGR) was found to be featured by decreased variables 
of acceleration capacity and deceleration capacity (AC/DC) [4–6]. FGR is known to be 
associated with an increased rate of fetal deterioration. We have speculated that AC/DC could be 
of use in the detection of antenatal fetal distress during FGR.  
The study was focused on the detection of the accuracy of AC/DC in diagnosing fetal 
distress. 
 
MATERIAL AND METHODS 
 In total, 124 pregnant women at 26–36 weeks of gestation were enrolled in the 
investigation. Only those who met the inclusion criteria and gave informed consent were 
included in the study (Tab. 1). The idiopathic FGR was detected by ultrasound. The population 
was divided into three groups. The patients with appropriate to gestational age fetuses (n = 32) 
were enrolled in Group I (control).  The patients with FGR and an absence of fetal distress (n = 
48) were observed in Group II. Lastly, the patients with FGR and fetal distress (n = 44) were 
included in Group III. Fetal cardiosignals were obtained via non-invasive fetal 
electrocardiography (NI-FECG) from the maternal abdominal wall. The Cardiolab Babycard 
equipment (Ukraine) was used in this study. The diagnosis of fetal distress was performed via 
Doppler ultrasonography according to the abnormal umbilical and ductus venosus hemodynamic 
variables. 
 The results obtained were analyzed with the chi-square test to compare data between 
groups. For the assessment of the difference between non-parametric variables, the Mann-
Whitney test was used. The significance was set at p-value < 0.05. For the statistical analysis of 
the relationship between X and Y, the correlations coefficients were estimated with Spearman’s 
test. SPSS for Windows Release 25.0 (SPSS Inc. Chicago, Illinois), the software was used for 
statistical analysis. The use of fetal HRV variables in diagnosing fetal distress was investigated. 
The sensitivity (Se) and specificity (Sp) of NST and AC/DC were calculated.  The relative risk 
(RR) of NST and AC/DC in fetal compromise prediction were also checked.  
 
RESULTS 
The average values of maternal age, body mass index, and parity were not different in 
Group I, Group II, and Group III (Tab. 2). The observed Group II and Group III patients had a 
higher manifestation of gestational hypertensive disorders and early onset FGR. 
 The maximally decreased AC/DC values were found in Group III (Tab. 3). The variables 
of phase rectified signal averaging were lower in Group II than in Group I, but higher than in 
Group III. Thus, the gradual decline of AC/DC was found amongst all study groups. 
 The investigation of the possible coupling between the AC/DC and fetal umbilical artery 
resistance index (RI) values in the study population revealed certain regularity. A significant 
relationship was found in Group I (R = 0.64, p < 0.05). A similar correlation was detected in 
growth-retarded fetuses. The values of the Spearmen correlation were almost equal in Group II 
and Group III (respectively, R = 0.62, p < 0.05; R = 0.68, p < 0.05).  Therefore, AC/DC could be 
speculated as a marker for fetal deterioration. The detected correlation between AC/DC and 
umbilical blood pH in all study groups supported this thesis. The values of correlation 
coefficients (R = 0.70, p < 0.05; R = 0.68, p < 0.05; R = 0.72, p < 0.05 in Group I, Group II, and 
Group III, respectively) reflected the possible use of AC/DC in fetal monitoring. 
The Se and Sp of nonreactive NST in diagnosing fetal distress were 65.22% (95% CI, 
49.75%–78.65%) and 60.87% (95% CI, 45.37% –74.91%). The Se and Sp of the reduced 
AC/DC were 97.73% (95% CI, 87.98%–99.94%) and 95.83% (95 CI, 85.75% – 99.49%). The 
RR for fetal during FGR in the case of nonreactive NST was 0.59 (95% CI, 0.38–0.90; p = 0.02).  
The same RR in the case of the reduced AC/DC was 0.04 (95% CI, 0.01–0.16; p < 0.001).   
 
DISCUSSION 
 Fetal electronic monitoring is known to have some serious restrictions in diagnosing fetal 
compromise. Only bradycardia is an evident sign of fetal deterioration [2, 3]. Several techniques 
were proposed for early detection of fetal distress. Our work has supported the opinion about the 
prospect of NI-FECG in fetal status detection [7, 8].  
Since the main problem of NI-FECG is a low signal-to-noise ratio, the use of the AC/DC 
variable is the most convenient tool for the assessment of HRV. AC/DC could be calculated even 
in case of prolonged episodes of signal loss. The high-quality tracing for 30 minutes is an issue 
for the obstetrician. Therefore, the use of STV and LTV is not obvious [8, 9]. But the assessment 
of NST is of insufficient accuracy [3].  
AC/DC is known to reflect the ability to increase or decrease heart rate [2, 5, 7]. The 
process of regulation captures the autonomic modulations. The lost autonomic function is a 
marker of a fatal event. The value of AC/DC is linked both to sympathetic and vagal activity. 
The disturbed AC/DC was found in myocardial infarction, heart failure, dilated cardiomyopathy, 
etc [5].  
We have found that the application of phase rectified signal averaging in the antenatal 
period showed high sensitivity and specificity in fetal distress detection. Since the main problem 
of NST assessment is a dependence on fetal stationary condition (“sleep” or awake), we could 
speculate that AC/DC has a universal ability to reflect fetal deterioration. 
The fetal HRV parameters are known to be associated with the process of neurological 
maturation. Therefore, the delay in neurological development has a negative projection on the 




 Fetal AC/DC is a prospective option for the detection of fetal compromise during fetal 
growth restriction.  
 
REFERENCES 
1. Hoyer D, Zebrowski J, Cysarz D, et al. Monitoring fetal maturation—objectives, 
techniques and indices of autonomic function. Physiological Measurement. 2017; 38(5): 
R61–R88, doi: 10.1088/1361-6579/aa5fca. 
2. Sholapurkar SL. Is fetal heart rate "deceleration area" the silver bullet for detection of 
acidemia? Am J Obstet Gynecol. 2018; 219(5): 510–512, doi: 
10.1016/j.ajog.2018.05.040, indexed in Pubmed: 29885303. 
3. Sholapurkar SL. Limits of current cardiotocography interpretation call for a major 
rethink. Am J Obstet Gynecol. 2017; 217(1): 92–93, doi: 10.1016/j.ajog.2017.02.048, 
indexed in Pubmed: 28274709. 
4. Smith V, Nair A, Warty R, et al. A systematic review on the utility of non-invasive 
electrophysiological assessment in evaluating for intra uterine growth restriction. BMC 
Pregnancy Childbirth. 2019; 19(1): 230, doi: 10.1186/s12884-019-2357-9, indexed in 
Pubmed: 31277600. 
5. Rivolta MW, Stampalija T, Frasch MG, et al. Theoretical value of Deceleration Capacity 
Points to Deceleration Reserve of Fetal Heart Rate. IEEE Trans Biomed Eng. 2020; 
67(4): 1176–1185, doi: 10.1109/TBME.2019.2932808, indexed in Pubmed: 31395532. 
6. Stampalija T, Casati D, Monasta L, et al. Brain sparing effect in growth-restricted fetuses 
is associated with decreased cardiac acceleration and deceleration capacities: a case-
control study. BJOG. 2016; 123(12): 1947–1954, doi: 10.1111/1471-0528.13607, 
indexed in Pubmed: 26395895. 
7. Hoyer D, Schmidt A, Gustafson KM, et al. Heart rate variability categories of fluctuation 
amplitude and complexity: diagnostic markers of fetal development and its disturbances. 
Physiol Meas. 2019; 40(6): 064002, doi: 10.1088/1361-6579/ab205f, indexed in Pubmed: 
31071684. 
8. Fuchs T, Grobelak K, Pomorski M, et al. Fetal heart rate monitoring using maternal 
abdominal surface electrodes in third trimester: can we obtain additional information 
other than CTG trace? Adv Clin Exp Med. 2016; 25(2): 309–316, doi: 
10.17219/acem/60842, indexed in Pubmed: 27627565. 
9. Behar J, Andreotti F, Zaunseder S, et al. A practical guide to non-invasive foetal 
electrocardiogram extraction and analysis. Physiol Meas. 2016; 37(5): R1–R35, doi: 
10.1088/0967-3334/37/5/R1, indexed in Pubmed: 27067431. 
10. Lakhno IV, Alexander S. Fetal autonomic malfunction as a marker of fetal distress in 
growth-restricted fetuses: three case reports. Obstet Gynecol Sci. 2019; 62(6): 469–473, 




Table 1. The inclusion and exclusion criteria 
Inclusion criteria Exclusion criteria 
FGR diagnosed via ultrasound. The fetal 
weight parameters were lower than 10th 
percentile 
Multiple gestation, any prodrome of maternal 
internal disease (cardiovascular disease, renal 




Table 2. Subject characteristics in the observed women 
Clinical feature, units Group I Group II Group III 
Maternal age, years 22.0 ± 4.2 22.8 ± 3.9 21.9 ± 4.6 
Body mass index 25.6 ± 4.4 25.8 ± 5.1 25.5 ± 5.4 




of cases (%) 
– 14 (29.1%) 26 (59.1%) 
Early-oset FGR 
(before 32 weeks), 
number of cases (%) 
– 19 (39.6%) 30 (68.2%) 
 
 
Table 3. The values of AC/DC in women with FGR 
Variable, units Group I Group II Group III 
AC, ms 2.18 ± 0.36 1.84 ± 0.23* 1.58 ± 0.32*/** 
DC, ms 2.11 ± 0.25 1.75 ± 0.22* 1.52 ± 0.28*/** 
* — the differences were statistically significant compared to control (Group I) (p < 0.05); ** — 
the differences were statistically significant compared to Group II (p < 0.05) 
 
